- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myositis, Inclusion Body in India
Total 141 results
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverIndia
-
Foundation for Innovative New Diagnostics, SwitzerlandIndian Council of Medical Research; University of Oxford; WHO, Special Programme...CompletedAcute Febrile IllnessUganda, Burkina Faso, Ghana, India, Nepal
-
PfizerRecruitingMyositisChina, United States, Japan, Korea, Republic of, Taiwan, Spain, Germany, Hungary, Argentina, Poland, Italy, Bulgaria, India, Belgium, France, Slovakia
-
PsiOxus Therapeutics LtdVeeda OncologyCompletedCancer CachexiaMalaysia, India, Germany
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverIndia
-
AllerganCompletedMacular Edema | Retinal Vein OcclusionUnited States, Poland, United Kingdom, Colombia, Spain, Korea, Republic of, Singapore, Brazil, New Zealand, Hong Kong, Italy, Canada, India
-
Pennington Biomedical Research CenterThe Coca-Cola CompanyCompletedChildhood ObesityUnited States, Australia, Brazil, Canada, China, Colombia, Finland, India, Kenya, Portugal, South Africa, United Kingdom
-
Endo PharmaceuticalsQuintiles, Inc.CompletedHIV Infections | Anorexia | Cachexia | HIV Wasting Syndrome | AIDS Wasting SyndromeUnited States, India, South Africa
-
Regeneron PharmaceuticalsBayerCompletedMacular Edema Secondary to Central Retinal Vein OcclusionUnited States, Canada, Colombia, Israel, India
-
NovaBay Pharmaceuticals, Inc.CompletedAdenoviral ConjunctivitisUnited States, India, Brazil, Sri Lanka
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery RestenosisFrance, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Belgium, Malaysia, Portugal, Russian Federation, Switzerland, India, Israel, Mexico
-
Zydus Lifesciences LimitedRecruitingObesity | Metabolic Syndrome | Dyslipidemias | Type 2 Diabetes | NAFLDIndia
-
CSL BehringCompletedFatigue | NSCLC | CachexiaCanada, Australia, Russian Federation, Georgia, Serbia, India, New Zealand, Poland, Romania
-
ShireTerminatedAdenoviral ConjunctivitisUnited States, Israel, France, India, Australia, Austria, Spain, Estonia, Hungary, Poland, South Africa, Canada, Germany, Italy, Peru, United Kingdom
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
Clearside Biomedical, Inc.TerminatedMacular Edema | Retinal Vein OcclusionSpain, United States, Taiwan, Canada, Hungary, Israel, Portugal, Australia, Poland, United Kingdom, Austria, Denmark, India, Italy, Philippines, Slovakia
-
Clearside Biomedical, Inc.TerminatedMacular Edema | Retinal Vein OcclusionUnited States, India, Australia, Hungary, New Zealand
-
Experimental and Clinical Research Center, a cooperation...RecruitingMultiple Sclerosis | Demyelinating Diseases | Optic Neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseItaly, United States, Argentina, Australia, Botswana, Brazil, Colombia, Denmark, France, Germany, India, Israel, Japan, Korea, Republic of, Spain, United Kingdom, Zambia
-
PfizerCompletedWeight Management | Treatment Of ObesityCanada, United States, Bulgaria, Spain, Mexico, India, Puerto Rico
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Overweight or ObesityUnited States, China, India, Taiwan, Japan, Brazil, Puerto Rico, Spain, Slovakia, Korea, Republic of
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Mexico, Brazil, Puerto Rico, Japan, Argentina, Russian Federation
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Japan, Netherlands, Korea, Republic... and more
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, India, Israel, Italy, United Kingdom, Spain, France, Sweden, Taiwan, Turkey, Germany, South Africa, Puerto Rico
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, Thailand, India, Malaysia, Turkey, United Kingdom, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Eli Lilly and CompanyActive, not recruitingObesity | Heart Failure With Preserved Ejection Fraction (HFpEF)China, United States, Taiwan, Mexico, Brazil, Argentina, Israel, India, Puerto Rico, Russian Federation
-
Eli Lilly and CompanyNot yet recruitingOverweight and ObesityUnited States, Canada, Australia, Germany, Mexico, Argentina, Brazil, Hungary, Austria, India, Poland, Slovakia, Spain, Netherlands, Turkey, Czechia, United Kingdom, Denmark, Puerto Rico, France, Israel
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Greece, Argentina, Korea, Republic of, Brazil, Czechia, Puerto Rico
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Obstructive Sleep Apnea | Type 2 DiabetesAustralia, United States, Mexico, Spain, India, Brazil, Romania, Taiwan, Argentina
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Knee Osteoarthritis | Obstructive Sleep Apnea | Knee Pain ChronicUnited States, Australia, Canada, Hungary, Mexico, India, Spain, United Kingdom, Taiwan, Romania, Brazil, Poland
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia